STRM Form 4: Executive Chairman converts shares and warrants in cash merger
Rhea-AI Filing Summary
Wyche T. Green III, Executive Chairman and Director of Streamline Health Solutions, reported disposals of company securities on 08/12/2025 pursuant to a merger. The Form 4 states the Merger Agreement dated May 29, 2025 became effective August 12, 2025, and each outstanding share of common stock was canceled and converted into the right to receive $5.34 in cash per share. The report shows dispositions and post-transaction beneficial ownership figures, and notes that certain restricted stock awards (11,199 shares) were converted into cash equal to their share count times the $5.34 Merger Consideration, less taxes.
The filing also reports treatment of outstanding warrants: Company warrants were canceled and either converted into a cash payment when the warrant exercise price was less than the $5.34 Merger Consideration or canceled for no consideration when the exercise price was equal to or greater than $5.34. The Form shows securities held in the account of 121G, LLC, which may be deemed beneficially owned by Mr. Green, and notes a 1-for-15 reverse split adjustment on October 4, 2024.
Positive
- Merger completed with clear cash consideration: Each outstanding common share was converted into the right to receive $5.34 per share in cash.
- Restricted awards addressed: The filing explicitly converts 11,199 restricted shares into cash equal to their share count times the $5.34 Merger Consideration, less taxes.
- Warrant treatment defined: The Form explains that warrants with exercise prices below the Merger Consideration convert to a cash payment formula, clarifying derivative settlement.
Negative
- Some warrants may be canceled for no consideration: The filing states any company warrant with an exercise price equal to or greater than the $5.34 Merger Consideration was canceled for no consideration.
- Insider loses direct equity stake: Reported dispositions tied to the merger indicate the reporting person’s outstanding shares and certain derivative positions were surrendered for cash.
Insights
TL;DR: Executive Chairman disposed shares and warrants in a cash merger paying $5.34 per common share; restricted awards converted to cash.
The Form 4 documents a corporate acquisition effective 08/12/2025 under a Merger Agreement dated 05/29/2025 whereby each outstanding common share was canceled for $5.34 in cash. Reported figures include 79,437 and 69,845 common shares shown in Table I and 59,829 warrant-related underlying shares in Table II; 11,199 restricted shares are specifically noted as converted to cash. The filing confirms mechanics for warrant treatment and that some securities are held via 121G, LLC, indicating indirect beneficial ownership. For investors, this is a material liquidity event that settles equity and many derivative claims in cash.
TL;DR: Disclosure is routine and complete for a Section 16 report tied to a merger; indirect ownership and reverse split are properly noted.
The Form 4 identifies the reporting person, corporate role (Executive Chairman and Director), transaction date (08/12/2025), and the Merger Agreement reference. It includes required explanatory footnotes: conversion of restricted stock awards, holding via 121G, LLC, a 1-for-15 reverse split adjustment (10/04/2024), and detailed warrant treatment. The filing appears to meet Section 16(a) disclosure requirements by reporting dispositions and the post-transaction beneficial ownership figures and by providing signatures. No additional governance irregularities are disclosed in the document text.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Warrant (right to buy) | 59,829 | $0.00 | -- |
| Disposition | Common Stock, $0.01 par value | 79,437 | $0.00 | -- |
| Disposition | Common Stock, $0.01 par value | 69,845 | $0.00 | -- |
Footnotes (1)
- This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 29, 2025, by and among the Issuer, Mist Holding Co. ("Parent"), and MD BE Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer, effective as of August 12, 2025, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of common stock, par value $0.01 per share, of the Company ("Common Stock") issued and outstanding as of immediately prior to the Effective Time was canceled and converted into the right to receive $5.34 in cash, without interest (the "Merger Consideration"). Includes 11,199 shares of restricted stock. Pursuant to the terms of the Merger Agreement, at the Effective Time, each restricted stock award corresponding to shares of Common Stock that was outstanding and unvested as of immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of Common Stock corresponding to such award of restricted stock immediately prior to the Effective Time, multiplied by (ii) the Merger Consideration, less applicable withholding taxes. The securities are held in the account of 121G, LLC (the "Holder") and may be deemed to be beneficially owned by Wyche "Tee" Green, III, the managing member of the holder. The Issuer effected a 1-for-15 reverse stock split of its common stock on October 4, 2024. The number of securities reported on this Form 4 has been adjusted to reflect the reverse stock split. Pursuant to the terms of the Merger Agreement, at the Effective Time, each warrant to purchase shares of Common Stock (each, a "Company Warrant") that was outstanding and unexercised and had a per share exercise price that was less than the Merger Consideration was canceled and converted into the right to receive (i) a cash payment equal to (A) the number of shares of Common Stock subject to the Company Warrant immediately prior to the Effective Time multiplied by (B) the excess, if any, of (x) the Merger Consideration over (y) the exercise price per share of Common Stock of such Company Warrant, less applicable withholding taxes. Each Company Warrant that was outstanding and unexercised with a per share exercise price that was equal to or greater than the Merger Consideration was canceled for no consideration.
